Targetech’s Newest Project: Neatcall

Targetech Innovation Center, which changed its name from Target Technology Center (perhaps to avoid confusion with the known US retailer Target), is a “new privatized dynamic high-technology center located in Israel.” Managed by experienced CEO Azriel Kadim, Targetech is a high-tech incubator located in Netanya that provides new start-ups an environment which “allows them to …

Israeli VC’s Invest $4.25M in US Based Proficiency

Israel’s Catalyst Investment, along with Carmel Ventures and Pitango Venture Capital have invested $4.25M in Boston-based Proficiency, a “leading developer of solutions that enable manufacturers and their suppliers to extract and share product knowledge from diverse engineering and manufacturing environments.” According to Yair Shamir, CEO of Catalyst, “Proficieny has revolutionized the way people view their …

Microsoft Wises Up With The Acquisition Of Israel’s YaData

The Israeli exit list for 2008 continues to grow. Microsoft announced today the acquisition of YaData (literally means “you knew” in Hebrew), a provider of advanced tools for the discovery of unique customer segments. Exact deal terms were undisclosed, but the deal is estimated to be in the $20-$30 million range according to estimates from …

Potentially Groundbreaking Cancer Treatment Needs Money

Professor Avraham Hochberg from the Hebrew University is the Chief Scientist of Biocancell, a two-year-old Israeli biotech startup specializing in the development of patient-oriented, targeted therapy for the treatment of a wide range of cancers. Biocancell was created with former Yissum President and CEO Avi Barak to develop and market Hochberg’s potentially revolutionary cancer treatment. …

Given Imaging not Given FDA Approval

Given Imaging’s new PillCam COLON was not approved for commercial distribution by the FDA on February 18, even though it’s been approved for commercial use in Israel and Europe. The Israeli company develops, produces and markets innovative, patient-friendly products that detect gastrointestinal disorders. The PillCam COLON is a new product based on the PillCam Platform. …

MGIC to Invest in the “New Google”

MGIC Plc, a new Israeli investment company, aims to find the “new google” by investing $100-300 thousand in Web 2.0 startups that are 6 – 9 months away from generating revenue. The founders include the founder of JDATE, Alon Carmel, the former British Ambassador to Israel Sir Andrew Burns, and Amir Raveh from MG Equity. …

New Fund Raises $162M to Invest In 17 Israel BioMed Companies

SCPVitalife Fund is a new Israel venture capital capital that has just raised a whole lot of money to invest in Israel’s promising biomed startups. Jeff Dykan, Managing Director of the fund said they “planned to raise $150 million but the fund is already oversubscribed at $162 million,” and that they may end up turning …

There can only be a single #1 recommendation platform for blogs: Outbrain Closes $5M A-Round

Outbrain announced the closing of a $5M A-round investment today, led by Gemini Israel Funds and Lightspeed Venture Partners. Outbrain’s seed investor GlenRock Israel, also participated in the round. Outbrain is a content recommendation and rating platform for blogs, news and RSS content. Outbrain’s star ranking widget (as seen on VC Cafe) allows users to …

The land of milk and honey: Ten Israeli companies annouce rounds in less than two weeks

Tonight was the Oscar night, but Hollywood stars are not the only ones getting the attention. No less than eight rounds were raised by Israeli companies in the last couple of weeks, totaling over $72 million. What are the reasons for so many announcements in such a short time? Is it newly raised funds, such …

VC Cafe Featured in “Blogs Every Israeli Startup Must Know”

TheMarker, Israel’s prominent business magazine and Haaretz, one of Israel’s largest newspapers, featured VC Cafe in a spread on “The Blogs That Every Israeli Startup Should Know“. Guy Grimland, editor of TheMarker IT, interviewed me a couple weeks ago and at the outset of the interview asked me “why should startups approach VC Cafe rather …

Exit mobile version